Key facts
- Wellysis’s last known valuation is $70.0M (Dec 2025).
- It has raised $26.0M; the latest was Later Stage VC ($12.0M) in Dec 2025.
- Notable investors include Tech Incubator Program for Startup, SBI Investment, Korea Investment Partners, Samsung Venture Investment, Kolon Investment — 16 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 16 names
- ·Watchlist + deal alerts for Wellysis
- ·The full record, as it builds
Funding rounds
No funding rounds for Wellysis are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Wellysis
Developer of a smart wearable device designed to offer cardiologists comprehensive and accurate diagnostic support. The company's device offers a live streaming electrocardiogram on a mobile device with AI-assisted analysis and interpretation and generates a report that analyzes the data and provides the results to the medical staff, enabling physicians to easily manage heart conditions for their patients.
- Sector
- Healthcare
- HQ
- Seoul, South Korea
- Founded
- 2019
- Employees
- 35
- Website
- wellysis.com/
- Ownership
- Privately Held (backing)
Wellysis doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Wellysis shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Wellysis in its N-PORT filings yet. We sweep new filings monthly.